Evidence map›Paper›PMID 41808230›Full record

ArticleResearch involvement and engagement2026

Patient involvement in the development of childhood, adolescent and young adult cancer survivorship guidelines: recommendations from EU-CAYAS-NET ambassadors.

Jikke Wams, Jaap den Hartogh, Hannah Gsell, Carina Schneider, Barbara Brunmair, Anna Zettl, Zuzana Tomášiková, Anita Kienesberger, Katie Rizvi, Ana M Totovina and 7 more

Abstract read
In one paragraph

Article in Research involvement and engagement, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jikke WamsPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. J.Wams-2@prinsesmaximacentrum.nl.
Jaap den HartoghPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Hannah GsellChildhood Cancer International - Europe, Vienna, Austria.
Carina SchneiderChildhood Cancer International - Europe, Vienna, Austria.
Barbara BrunmairChildhood Cancer International - Europe, Vienna, Austria.
Anna ZettlChildhood Cancer International - Europe, Vienna, Austria.
Zuzana TomášikováChildhood Cancer International - Europe, Vienna, Austria.
Anita KienesbergerChildhood Cancer International - Europe, Vienna, Austria.
Katie RizviYouth Cancer Europe, Cluj-Napoca, Romania.
Ana M TotovinaYouth Cancer Europe, Cluj-Napoca, Romania.
Roderick SkinnerGreat North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Jeroen Te DorsthorstPanCare, Bussum, The Netherlands.
Helena J H van der PalPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Elvira C van Dalen *Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Renée L Mulder *Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
EU-CAYAS-NET ambassadors and consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurvivors of Childhood, Adolescent, and Young Adult (CAYA) cancer can face long-term health complications due to adverse effects of cancer and its treatment, necessitating lifelong follow-up care. Clinical practice guidelines (CPGs) provide evidence-based recommendations for late effects surveillance. Despite the recognized value of patient involvement, its integration into CPG development remains inconsistent and underexplored.

objectiveThis study aimed to identify effective strategies for integrating patient involvement across all phases of CPG development in CAYA cancer survivorship care.

methodsThis qualitative study consisted of a half-day workshop that was conducted during the European Network of Youth Cancer Survivors (EU-CAYAS-NET) ambassador training event in November 2023 in Vienna, Austria. Forty-nine project ambassadors, all CAYA cancer survivors, participated in presentations and interactive sessions, including breakout discussions and mind-mapping exercises. Data from plenary discussions and mind-maps were analyzed using qualitative content analysis to extract key recommendations and conditions for successful patient involvement in CPG development.

resultsParticipants formulated 12 recommendations and 11 conditions for effective patient involvement in CPG development, structured across four phases: recruitment, preparation, development, and dissemination. Key areas included clarity, support, collaboration, respect, feasibility, and communication. DISCUSSION: These findings emphasize the need for a systematic approach to patient involvement, ensuring patient representatives are integrated as active stakeholders throughout CPG development, in a role that fits the goal of each guideline.

conclusionThis study proposes a structured framework for patient involvement in CAYA cancer survivor CPG development, advocating for continuous patient involvement to enhance guideline quality, adoption, and impact. Future efforts should align with our proposed approach to patient involvement in CPG development to establish standardized practices within existing frameworks.

Indexed as

Cancer survivorshipChildhood adolescent and young adult cancerClinical practice guidelinesParticipatory researchPatient involvementPatient representatives

Identifiers

PMID41808230
PMCPMC13255260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.